Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $641.13 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $354.90 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $121.84 | 1 | $0 (2024) |
| Lilly USA, LLC | $30.81 | 2 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $23.01 | 2 | $0 (2017) |
| Purdue Pharma L.P. | $17.83 | 1 | $0 (2017) |
| Amgen Inc. | $17.62 | 1 | $0 (2017) |
| Braemar Manufacturing, LLC | $17.20 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $16.86 | 1 | $0 (2017) |
| AbbVie, Inc. | $16.77 | 1 | $0 (2017) |
| Ironwood Pharmaceuticals, Inc | $13.19 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $137.04 | 2 | AstraZeneca Pharmaceuticals LP ($121.84) |
| 2023 | $48.54 | 1 | Novo Nordisk Inc ($48.54) |
| 2021 | $17.98 | 1 | Novo Nordisk Inc ($17.98) |
| 2019 | $204.47 | 3 | Novo Nordisk Inc ($187.27) |
| 2018 | $101.11 | 1 | Novo Nordisk Inc ($101.11) |
| 2017 | $131.99 | 9 | Takeda Pharmaceuticals America, Inc. ($23.01) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Obesity | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/30/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $48.54 | General |
| Category: Obesity | ||||||
| 05/04/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
| 10/01/2019 | Braemar Manufacturing, LLC | Cardiac Monitoring Suite (Device) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Cardiology | ||||||
| 05/08/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $72.43 | General |
| Category: Diabetes | ||||||
| 03/07/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $114.84 | General |
| Category: Obesity | ||||||
| 06/14/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $101.11 | General |
| Category: Obesity | ||||||
| 03/20/2017 | Purdue Pharma L.P. | OXYCONTIN (Drug), HYSINGLA ER, BUTRANS | Food and Beverage | Cash or cash equivalent | $17.83 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/27/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/20/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Gout/Rheumatology | ||||||
| 02/13/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Endocrinology | ||||||
| 02/06/2017 | GlaxoSmithKline, LLC. | ANORO (Drug), BREO | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: RESPIRATORY | ||||||
| 01/24/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $16.77 | General |
| 01/12/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Diabetes | ||||||
| 01/09/2017 | Ironwood Pharmaceuticals, Inc | ZURAMPIC (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Rheumatology | ||||||
| 01/05/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: Central Nervous System (CNS) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 83 | 13,327 | 25,328 | $1.8M | $554,831 |
| 2022 | 79 | 17,739 | 33,913 | $1.6M | $516,502 |
| 2021 | 77 | 18,597 | 32,320 | $1.7M | $529,343 |
| 2020 | 83 | 18,991 | 31,791 | $1.7M | $499,381 |
All Medicare Procedures & Services
322 procedure records from CMS Medicare Utilization — Page 1 of 13
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 744 | 1,451 | $422,241 | $124,355 | 29.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 484 | 484 | $118,580 | $60,247 | 50.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 181 | 181 | $134,302 | $51,174 | 38.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 31 | 2,761 | $107,679 | $50,333 | 46.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 223 | 256 | $108,800 | $28,595 | 26.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 255 | 258 | $32,333 | $19,444 | 60.1% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 151 | 151 | $40,619 | $19,272 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 240 | $45,033 | $14,599 | 32.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 752 | 1,656 | $36,432 | $13,910 | 38.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 574 | 841 | $70,644 | $13,824 | 19.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 620 | 1,056 | $72,864 | $13,803 | 18.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 597 | 923 | $40,612 | $9,517 | 23.4% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 279 | 514 | $45,232 | $8,504 | 18.8% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 59 | 59 | $18,605 | $8,247 | 44.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 493 | 851 | $45,103 | $8,082 | 17.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 177 | 277 | $42,381 | $8,036 | 19.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 267 | 270 | $15,120 | $7,876 | 52.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 557 | 812 | $38,164 | $7,163 | 18.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 34 | 35 | $19,075 | $7,040 | 36.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 608 | 898 | $35,920 | $6,834 | 19.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 156 | 156 | $10,140 | $6,068 | 59.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 33 | 38 | $14,706 | $5,822 | 39.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 186 | 186 | $10,974 | $5,426 | 49.4% |
| 90739 | Hepatitis b vaccine (hepb), cpg-adjuvanted, adult dosage, 2 dose or 4 dose schedule, for intramuscular use | Office | 2023 | 21 | 31 | $11,408 | $4,684 | 41.1% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 51 | 84 | $17,892 | $3,398 | 19.0% |
About Dr. James Adams, MD
Dr. James Adams, MD is a Family Medicine healthcare provider based in Leland, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497750178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Adams, MD has received a total of $641.13 in payments from pharmaceutical and medical device companies, with $137.04 received in 2024. These payments were reported across 17 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($641.13).
As a Medicare-enrolled provider, Adams has provided services to 68,654 Medicare beneficiaries, totaling 123,352 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 322 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Leland, NC
- Active Since 06/17/2005
- Last Updated 03/18/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1497750178
Products in Payments
- Saxenda (Drug) $215.95
- FARXIGA (Drug) $121.84
- Ozempic (Drug) $90.41
- Wegovy (Drug) $48.54
- OXYCONTIN (Drug) $17.83
- Prolia (Biological) $17.62
- Cardiac Monitoring Suite (Device) $17.20
- PRALUENT (Drug) $16.86
- TRULICITY (Drug) $15.61
- ZEPBOUND (Drug) $15.20
- ZURAMPIC (Drug) $13.19
- Uloric (Drug) $12.77
- ANORO (Drug) $11.10
- Trintellix (Drug) $10.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Leland
Kira Alatar, Md, MD
Family Medicine — Payments: $6,634
Robert Johnson, Md, MD
Family Medicine — Payments: $5,711
Dr. Anette Bodoky, M.d, M.D
Family Medicine — Payments: $3,461
Dr. Lekeshia Jarrett, Md, MD
Family Medicine — Payments: $2,607
Gloria Vreeland, M.d, M.D
Family Medicine — Payments: $1,629
Rajya Atluri, M.d, M.D
Family Medicine — Payments: $1,041